Ligand · HJ0
HJ0 · 4-azanyl-7-(1-methylcyclopropyl)-~{N}-(5-methyl-1~{H}-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide
HJ0, 4-azanyl-7-(1-methylcyclopropyl)-~{N}-(5-methyl-1~{H}-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide (C15 H17 N7 O, 311.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- HJ0
- Formula
- C15 H17 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
HJ0 in 2 structures; the first of them:
- 7DUA · Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex… · HJ0 A1101 · binds LEU730, GLY731, PHE735, VAL738, ALA756, LYS758, GLU775, LEU779 and 9 more
- 7DUA · Crystal structure of human proto-oncogene tyrosine-protein kinase receptor ret in complex… · HJ0 A1101 · binds LEU730, GLY731, PHE735, VAL738, ALA756, LYS758, GLU775, LEU779 and 9 more
Residues it binds most
LEU 4, ALA 4, GLU 4, SER 4, VAL 4, ASP 4, GLY 4, LYS 4, PHE 4, TYR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.